StockNews.AI
SRTS
StockNews.AI
25 days

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

1. Sensus Healthcare faced financial losses and stock decline. 2. Second quarter earnings missed estimates, causing a price drop of 35.32%. 3. Investigation into potential securities law violations is underway. 4. Legal firm invites affected investors to discuss their options. 5. Revenue decreased by 20.7% year-over-year due to lower unit sales.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The significant earnings miss and price drop reflect deep market concerns about SRTS's viability. Historical instances show that sustained revenue declines can lead to prolonged stock depreciation.

How important is it?

The article directly addresses ongoing legal issues impacting SRTS, which could affect stock performance.

Why Short Term?

Immediate investor reaction to lawsuits can influence stock prices quickly, as seen in similar cases. Ongoing investigations could amplify short-term volatility.

Related Companies

SPYTLTIWM
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sensus (SRTS) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Sensus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 31, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sensus Healthcare, Inc. (“Sensus” or the “Company”) (NASDAQ:SRTS) on behalf of Sensus stockholders. Our investigation concerns whether Sensus has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On August 7, 2025, Sensus reported its financial results for the second quarter of 2025, revealing a second quarter GAAP earnings-per-share figure of -$0.06, missing estimates by $0.09, and revenue of $7.3M, representing a -20.7% year-over-year decline and missing estimates by $2M. Sensus attributed the decrease in revenue primarily to a lower number of units sold to a large customer, partially offset by growth in recurring revenue from Fair Deal Agreements. On this news, Sensus's stock price fell $1.89 per share, or 35.32%, to close at $3.46 per share on August 8, 2025. If you purchased or otherwise acquired Sensus shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News